Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Pigs cloned for first time

Credit: ©PPL Therapeutics

PPL Therapeutics (Edinburgh, UK), the company that, along with the Roslin Institute, cloned Dolly the sheep, announced on March 14 that it had created the first pigs cloned from adult cells. Independent DNA testing of blood from the five female piglets–Millie, Christa, Alexis, Carrel, and Dotcom–confirmed that their DNA was identical to that of the cells used to produce them and different from that of the surrogate mother. PPL says the successful cloning of the pigs opens the door to producing modified pigs whose organs and cells can be transplanted into humans. The method used to produce the piglets differs from that used to create Dolly, and the company has applied for a patent for “additional inventive steps”. PPL says the next stage is to create “knock-out” pigs, in which the gene for α-1-3 gal transferase is inactivated. That gene is responsible for the sugar group in pig cells that is recognized by the human immune system as foreign, thus causing transplant rejection. PPL says it hopes to begin clinical trials for xenotransplantation of pig organs in as little as four years.


Rights and permissions

Reprints and Permissions

About this article

Cite this article

Grisham, J. Pigs cloned for first time. Nat Biotechnol 18, 365 (2000).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing